Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation ...

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a ...

Sure, it’s great for cracked heels and stubborn calluses, but we also reach for it to rescue chapped lips, peeling cuticles, ...

DelveInsight's House Dust Mite Disease Market Insights report includes a comprehensive understanding of current treatment practices, house dust mite disease emerging drugs, market share of individual ...

Affidea Group, Europe's leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including ...

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...

The house dust mite disease market is experiencing steady growth, driven by rising global prevalence of allergic rhinitis and asthma linked to indoor allergens. Increasing adoption of allergen-specifi ...

For Troy, his wife Zoe and children Oakley and Nataya, the use of virtual fencing marks a turning point in how their 3100 hectare mixed farming operation is run - and where it's h ...

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...